Candel Therapeutics, Inc. (CADL) Insider Ownership

Historic Insider Ownership Trends

CADL's three largest insider shareholders as of June 18, 2026 are Estuardo Aguilar-Cordova (Chief Scientific Officer, 1.10Mn shares), Laura K. Aguilar (Chief Medical Officer, 1.03Mn shares), Estuardo Aguilar-Cordova (TenPercentOwner, 283.79K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Jason Amello Chief Financial Officer 202,009 0 30 Nov, 2023
John J Canepa Chief Financial Officer 10,125 0 02 Aug, 2021
William Garrett Nichols Chief Medical Officer 52,493 0 30 Jul, 2025
Nathan Caffo Chief Business Officer 6,000 0 02 Aug, 2021
Gary J. Nabel - 5,353 0 26 Jun, 2025
Christopher Martell - 0 283,514 02 Aug, 2021
Paul Peter Tak Chief Executive Officer 268,566 0 26 Jun, 2025
Laura K. Aguilar Chief Medical Officer 1,033,840 0 10 May, 2022
Estuardo Aguilar-Cordova Chief Scientific Officer 1,097,032 0 10 May, 2022
Francesca Barone Chief Scientific Officer 100,809 0 26 Jun, 2025
Seshu Tyagarajan Chief Technology Officer 90,865 0 26 Jun, 2025
Nicoletta Loggia - 2,141 0 26 Jun, 2025
Charles Schoch Chief Financial Officer 43,391 0 26 Jun, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
31 Mar, 2026 Nicoletta Loggia Stock Option (Right to Buy) A 779 $4.11 779 D A
31 Mar, 2026 Nicoletta Loggia Stock Option (Right to Buy) A 779 $4.11 779 D A
26 Jan, 2026 Charles Schoch Stock Option (Right to Buy) A 232,000 $0.00 232,000 D A
26 Jan, 2026 William Garrett Nichols Stock Option (Right to Buy) A 136,500 $0.00 136,500 D A
26 Jan, 2026 Seshu Tyagarajan Stock Option (Right to Buy) A 154,000 $0.00 154,000 D A
26 Jan, 2026 Paul Peter Tak Stock Option (Right to Buy) A 629,000 $0.00 629,000 D A
26 Jan, 2026 Francesca Barone Stock Option (Right to Buy) A 232,000 $0.00 232,000 D A
26 Jan, 2026 Paul Peter Tak Stock Option (Right to Buy) A 629,000 $0.00 629,000 D A
26 Jan, 2026 Seshu Tyagarajan Stock Option (Right to Buy) A 154,000 $0.00 154,000 D A
26 Jan, 2026 Charles Schoch Stock Option (Right to Buy) A 232,000 $0.00 232,000 D A
26 Jan, 2026 William Garrett Nichols Stock Option (Right to Buy) A 136,500 $0.00 136,500 D A
28 Jul, 2025 William Garrett Nichols Common Stock A 937 $1.29 53,430 D M
28 Jul, 2025 William Garrett Nichols Common Stock A 937 $1.29 53,430 D M
28 Jul, 2025 William Garrett Nichols Common Stock D 937 $6.98 52,493 D S
28 Jul, 2025 William Garrett Nichols Common Stock D 937 $6.98 52,493 D S
28 Jul, 2025 William Garrett Nichols Stock Option (Right to Buy) D 937 $0.00 29,377 D M
28 Jul, 2025 William Garrett Nichols Stock Option (Right to Buy) D 937 $0.00 29,377 D M
30 Jun, 2025 William Garrett Nichols Common Stock A 781 $1.29 53,274 D M
30 Jun, 2025 William Garrett Nichols Common Stock A 781 $1.29 53,274 D M
30 Jun, 2025 William Garrett Nichols Common Stock D 781 $5.04 52,493 D S